Clinical trial
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta…
NCT00106028 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00106028 |
|---|---|
| Title | Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children |
| Official title | Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteogenesis Imperfecta |
| Intervention type | Drug |
| Interventions | risedronate sodium (Actonel), Placebo |
| Enrollment | 143 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2008 |
| Completion | Mar 1, 2010 |
| First posted | Mar 21, 2005 |
| Last update posted | Apr 22, 2013 |
| Countries | Australia, Belgium, Chile, Czechia, Finland, Germany, Hungary, Italy, Poland, South Africa, Spain, United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: